Overview
Description
Willow Biosciences Inc. is a biotechnology company that focuses on developing and producing high-purity, plant-derived compounds. The company's primary function is to utilize advanced synthetic biology and genetic engineering techniques to create pharmaceutical-grade ingredients used in health and wellness, personal care, and food and beverage industries. Willow Biosciences is especially noted for its work on cannabinoid production, where it employs bio-synthetic processes to produce cannabinoids without the cultivation of cannabis plants, ensuring sustainable and cost-effective manufacturing. With its headquarters in Canada and a presence in related global markets, Willow Biosciences contributes significantly to the supply of biosynthesized compounds, impacting both the pharmaceutical and consumer goods sectors with its innovative approaches.
About
CEO
Dr. Chris Savile
Employees
19
Address
202, 1201-5th Street SW
Calgary, T2R 0Y6, AB
Canada
Calgary, T2R 0Y6, AB
Canada
Phone
403-910-5140
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
United States
MIC code
OTCB